The FusionPlex Pan Solid Tumor v2 panel is a targeted next-generation sequencing (NGS) research product that expands on the FusionPlex Solid Tumor panel to include key fusions and variants relevant across solid tumors and sarcomas in 137 genes. This panel uses Anchored Multiplex PCR (AMP™)-based enrichment to detect all fusions associated with the genes in a single sequencing product, even without prior knowledge of fusion partners or breakpoints.
Solid Tumor
AKT3 (V-akt murine thymoma viral oncogene homolog 3), ALK (Anaplastic lymphoma kinase), BRAF (B-raf proto-oncogene), EGFR (Epidermal growth factor receptor), ERG (ETS Transcription Factor ERG), ETV1 (ETS Variant Transcription Factor 1)
See More ...
Next-Generation Sequencing (NGS)